All news

30/09/2015

DigitalforLife: discover the first challenges!

Atlanpole Biotherapies and Images & Networks competitive clusters offer, via DigitalForLife, a truly open laboratory, a call to challenges to experiment and develop new methods of treatment in the field of health, through digital technology. On May the 28th, project developers, start-up companies, laboratories, health care centers, large companies, mutual companies, institutions, ... took part in this first event, where the projects were presented!

27/05/2015

CESTI IHU: Unlocking messenger RNA’s potential in order to develop new biotherapeutic products.

The messenger RNA is now considered to be a new generation of natural biotherapeutics, which can use the ability of the body to produce its own therapeutic proteins.

27/05/2015

Woman of the month : Caroline Le Guiner, at the forefront of research on rare diseases

In 2003, Caroline Le Guiner completed her PhD in Sciences, specializing in genetic and molecular biology particularly in the study of the regulation of alternative splicing. During this work, she was attached to the Cancer Research Institute in Nantes. After years of basic research on the cellular regulation mechanisms, she aspires to use the results of her work in a more concrete way. Thus, her great interest in medicine and patients led her towards applied research. Philippe Moullier, a medical doctor by training, who is also a researcher at INSERM and the founder of Nantes Gene Therapy Laboratory, accepted her in for her post doctorate work. 11 years later, she is still working in the same lab, where she is leading a gene therapy research program, whose goal is to develop drugs to treat a rare disease, Duchenne muscular dystrophy. A first clinical trial is expected to begin within a few months.

26/05/2015

Financing: support the development of Carlina Technologies

Logo Carlina Technologies

The company, a member of Atlanpole Biotherapies and accompanied by Angers Technopole, is actively seeking funding to continue its product development activities.

22/05/2015

Biosims announces the completion of a fundraising of €1m

Logo BioSIMS

[Press Release] Biosims, based in Rouen (Normandy) is a young and innovative company specialized in multiplex and ultrasensitive bioanalysis technologies. It develops, produces and sells the Dynaxi analyser based on a proprietary technology protected by several international patents. This fundraising was conducted with GO CAPITAL, who made a second round of investment of €900,000, and Normandy Business Angels, who co-invested €150,000.